Clinical Trial Billing Compliance at UAB

Size: px
Start display at page:

Download "Clinical Trial Billing Compliance at UAB"

Transcription

1 Clinical Trial Billing Compliance at UAB Carolyn P. Whitmire, MBA, CHRC Director, Research Implementa?on Co- Administra?ve Director, Clinical Trials Office

2 UAB Infrastructure Campus and Health System are separate en??es Separate Health System billing offices and systems Hospital Healthquest Health Services Founda?on (HSF) - IDX Electronic medical record (EMR) - Cerner Clinical trial ac?va?on process occurs on campus side Campus, Health System and School of Medicine partner to fund a Clinical Trials Office concept Coordinated effort between VP for Research, School of Medicine and Health System to improve the clinical trial ac?va?on process and posi?on UAB to grow its clinical trial business

3 UAB and Clinical Trials Over 3,000 ac?ve IRB protocols 800 1,000 ac?ve clinical trials u?lize clinical services provided and billed by UAB Health System

4 History of UAB and Clinical Trial Billing Compliance Created Research Compliance Office in response to OIG subpoena for informa?on about clinical trials billing and effort repor?ng Created a paper- based clinical trial billing no?fica?on (CTBN) process to inform the Health System billing offices Implemented a robust clinical trial billing audi?ng plan and required training for effort repor?ng Implemented Coverage Analysis Process in 2005/2006 Harmoniza?on of billing grid, contract, budget and informed consent Implemented SiteMinder Clinical Trial Management System (CTMS) to automate the paper CTBN process Focused only on those research projects with services provided and billed by UAB Health System Research Compliance Office renamed University Compliance Office and scope of responsibili?es expanded in 2010

5 Clinical Protocol Ac;va;on Process UAB Clinical Protocol Ac?va?on Process Coverage Analysis should occur early in the ac?va?on process, preferably prior to: Submission to Office of Sponsored Programs Submission to Office of the Ins?tu?onal Review Board Ini?a?on of budget nego?a?ons Approved billing matrix is built into a CTMS to drive our billing compliance no?fica?ons

6 Current CTMS Process Overview

7 No;fica;ons from CTMS to Billing Offices Data Feed #1. SM budget must be finalized no less than 24 hours prior to the first subject enrolled date. The data feed is generated daily at 11pm and sent to Hospital and HSF to be worked the next business day. MSO creates occ/med dictionary entry for the study, and Hospital Lab initiates steps to create institutional lab account, if applicable. Hospital PFS takes no action in HQ at this point. Data Feed #2. Patient record created in SM and patient linked to study on the day consent is signed. The data feed is generated daily at 11pm and sent to Hospital and HSF to be worked the next business day. MSO creates a case for the patient in IDX. Hospital Lab/Hospital PFS does not take action on this data feed.. Data Feed #3. Research appointments should be added to the SM calendar no later than 5pm the day before the visit date. NOTE: There is an exception report here which includes visits scheduled in SM after the visit date. This data feed is generated daily at 11pm and sent to Hospital and HSF to be worked the next business day. MSO and Hospital PFS use this information to compare to accounts in HQ and appointments in IDX and where there is a match, the appointment/account is flagged to be billed after receipt of a CTBN. Data Feed #4. For visits where the appointment is in the SM calendar by 5pm the day before the visit date, the visit can be kept no later than 48 hours (excluding weekends) after the visit date. CTBN s are generated every 2 hours for SiteMInder visits that have been kept. This data is available to the Health System billing offices via an on- line database. For a visit where the criteria described for data feed #3 is not met, the visit must be kept on the day of the visit.

8 Clinical Trial Billing No;ce

9 Problems with Current Process Limited informa?on to assess the performance of our clinical trial book of business Unclear policies and expecta?ons for clinical trial budget development and financial management Financial losses due to under- es?ma?on of costs or over- es?ma?on of enrollment Duplica?on of effort by study teams leads to tardy CTBNs to billing offices Inefficient or unavailable tools for financial management of clinical trials Inefficient and manual processes

10 Changes on the Horizon Require a coverage analysis for all clinical trials Require an internal cost analysis (i.e. budget) for all clinical trials Must be approved by department or division Require the use of a CTMS to manage all aspects of a clinical trial Implement Cerner s PowerTrials product to support ordering of clinical services for research {this process facilitates billing compliance}

11 Future State with CTMS and PowerTrials (EMR)

12 Clinical Trial Budget and Billing Plan Downloadable version to excel to reflect costs versus charge by ac?vity and by visit

13 Research PowerPlan Segregates Research Only versus Rou;ne Care Research SOC Billing Charges appear on ins?tu?onal account; automa?cally discounted to the correct research rate Charges appear on pa?ent account with appropriate billing modifiers

14 PowerTrials Implementa;on Approach Begin with most frequently u?lized clinical services clinical lab and radiology Inpa?ent clinical trials to be addressed in subsequent phase Design process for protocol amendments and their impact on the clinical trial budget and research powerplan A CTBN (detailed account of visit ac?vity per pa?ent) will con?nue to exist in CTMS but use of this informa?on will transi?on to more of a monitoring/compliance tool versus a tool used in day- to- day billing ac?vi?es

15 Challenges Blinded studies Clinical services that should not be part of pa?ent s medical record Coordinated approach to pa?ent care clinical care and research care

16 Key Lessons Learned Execu?ve and School leadership and support is essen?al Require the use of a clinical trial management system (CTMS) to facilitate the overall management of a clinical trial Integrate CTMS with other systems to the extent possible Include study team members in the design of future state Develop clear policies and expecta?ons along with clearly defined roles/responsibili?es Design processes with input from subject maker experts and include built- in compliance checks Implement a robust monitoring plan for billing compliance

17 Ques;ons????? Contact informa;on: Tracy Popp Norton Healthcare Carolyn Whitmire The University of Alabama at Birmingham

Help Your Account Holders Instantly Fund & Switch Their Primary Account to Your Financial Ins<tu<on

Help Your Account Holders Instantly Fund & Switch Their Primary Account to Your Financial Ins<tu<on Presentation and video replay will be provided within one week. Have questions? Use the questions panel - we ll field them as we go and during the Q&A recap Help Your Account Holders Instantly Fund & Switch

More information

Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites

Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites SAMPLE CUSTOM MARKET RESEARCH REPORT Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites An Analysis of Company- Specific Results From the CenterWatch 2013 Survey of Global InvesBgaBve

More information

Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites

Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites SAMPLE CUSTOM MARKET RESEARCH REPORT Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites An Analysis of Company- Specific Results From the CenterWatch 2013 Survey of Global InvesBgaBve

More information

National Research Network 2012 Benchmark Report

National Research Network 2012 Benchmark Report National Research Network 212 Benchmark Report The National Research Network 212 Benchmark Report pulls together real world performance data from hospitals, universities and government agencies across

More information

National Research Network 2011 Benchmark Report

National Research Network 2011 Benchmark Report National Research Network 211 Benchmark Report The National Research Network 211 Benchmark Report pulls together real world performance data from hospitals, universities and government agencies across

More information

IBM Clinical Trial Management System for Sites

IBM Clinical Trial Management System for Sites Service Description IBM Clinical Trial Management System for Sites This Service Description describes the Cloud Service IBM provides to Client. Client means the contracting party and its authorized users

More information

Research and the EHR: Process Improvement Through Integration

Research and the EHR: Process Improvement Through Integration Research and the EHR: Process Improvement Through Integration Session 160, March 8, 2018 Arash Naeim, MD PhD, Chief Medical Research Officer, UCLA Health System Marti Arvin, VP of Audit Strategy, CynergisTek

More information

IBM Clinical Trial Management System for Sites

IBM Clinical Trial Management System for Sites Service Description IBM Clinical Trial Management System for Sites This Service Description describes the Cloud Service IBM provides to Client. Client means the contracting party and its authorized users

More information

Clinical Trials Office VPR CTO

Clinical Trials Office VPR CTO Clinical Trials Office VPR CTO Velos eresearch Mysti M. Trainer Budget Analyst - Associate Who is the VPR-CTO? Serve Under the Vice President for Research Part of the Research Administration We work closely

More information

The Beryl Ins,tute Pa,ent Experience Webinar Series

The Beryl Ins,tute Pa,ent Experience Webinar Series www.theberylins,tute.org The Beryl Ins,tute Pa,ent Experience Webinar Series Defining Pa,ent Experience The sum of all interactions, shaped by an organization s culture, that influence patient perceptions

More information

Sponsor/Investigator Responsibilities

Sponsor/Investigator Responsibilities Sponsor/Investigator Responsibilities Marian Serge, RN Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health Food and Drug Administration Marian.Serge@fda.hhs.gov

More information

A Management Systems Approach to Ergonomics Programs. Elise Condie, M.S., CPE Senior Consultant

A Management Systems Approach to Ergonomics Programs. Elise Condie, M.S., CPE Senior Consultant A Management Systems Approach to Ergonomics Programs Elise Condie, M.S., CPE Senior Consultant What is OHSAS 18001? An interna)onal standard for occupa)onal health and safety management systems (OHSMS)

More information

Successful Changes with Integrated Change and Project Management

Successful Changes with Integrated Change and Project Management Successful Changes with Integrated Change and Project Management Markus F. Wanner, Managing Partner, Representative of Management, Tiba Management Consulting, Munich/ Germany 1 A way to success?? 2 Agenda

More information

Module One: Produc.ve Management Methodology for Health Services (PMMHS) An Introduc.on Part 2

Module One: Produc.ve Management Methodology for Health Services (PMMHS) An Introduc.on Part 2 Module One: Produc.ve Management Methodology for Health Services (PMMHS) An Introduc.on Part 2 What is PMMHS? It is a methodology for the management of health services based on produc.on, efficiency, resources

More information

Top 5 Ways to Improve Your Billing & Collec=ons

Top 5 Ways to Improve Your Billing & Collec=ons Top 5 Ways to Improve Your Billing & Collec=ons Presenters: Jillian Longpre Vice President Franco Rizzolo, DC CEO Brought to you by: Industry leading Educa1on Cer1fied Partner Program Please ask ques1ons

More information

OnCore Billing Compliance Workflow Demonstration

OnCore Billing Compliance Workflow Demonstration Srini Kalluri, Founder, President & Chief Customer Officer Carrie Nemke, Business Development Manager CTMS Support of Billing Compliance Best Practices Research Compliance Conference Austin TX, June 2013

More information

Pla$orm for Engaging Everyone Responsibly (PEER)

Pla$orm for Engaging Everyone Responsibly (PEER) Pla$orm for Engaging Everyone Responsibly (PEER) We begin with a novel perspec

More information

Share-based Payment IFRS REPORTING

Share-based Payment IFRS REPORTING YOUR PARTNER IN PARTICIPATION SOLUTIONS Innova3ve So4ware You Can Trust Share-based Payment IFRS REPORTING Introduc3on In many organizes ICT, Finance, Human Resources and Legal are separate departments

More information

Transla(ng Principles to Performance Crea(ng a Global System to Promote Responsible Conduct of Human Research by Physicians

Transla(ng Principles to Performance Crea(ng a Global System to Promote Responsible Conduct of Human Research by Physicians Enhancing Safety, Quality and Efficiency in Medicines Development and Health Research through Systems Solu>ons Transla(ng Principles to Performance Crea(ng a Global System to Promote Responsible Conduct

More information

WORKLOAD PLANNING, WORK EFFORT MANAGEMENT & WORK FLOW DIAGRAMS

WORKLOAD PLANNING, WORK EFFORT MANAGEMENT & WORK FLOW DIAGRAMS WORKLOAD PLANNING, WORK EFFORT MANAGEMENT & WORK FLOW DIAGRAMS TIPS AND TECHNIQUES FOR MANAGING YOUR SITE RESOURCES Hosted by Dial-In Information: Webinar ID: 831655168 Audio: (888) 824-5783 Access Code:

More information

Protec'ng Privacy in the Archives: Preliminary Explora'ons of Topic Modeling for Born- Digital Collec'ons

Protec'ng Privacy in the Archives: Preliminary Explora'ons of Topic Modeling for Born- Digital Collec'ons Protec'ng Privacy in the Archives: Preliminary Explora'ons of Topic Modeling for Born- Digital Collec'ons Tim Hutchinson 13 December 2017 IEEE 2017: 2 nd CAS Workshop Guiding ques'ons/context! High volume

More information

WHAT IS OUR RESEARCH PORTFOLIO?

WHAT IS OUR RESEARCH PORTFOLIO? Clinical Research Management System Online Collaborative Research Environment (OnCore) Forte Research Systems Christian Stephens Office of Research Informatics Project Manager Mike Neuenfeldt Forte Project

More information

IXRS DATA TO INFORMED DECISION MAKING. Linda Chan-Kim October 2015

IXRS DATA TO INFORMED DECISION MAKING. Linda Chan-Kim October 2015 IXRS DATA TO INFORMED DECISION MAKING Linda Chan-Kim October 2015 Table of Contents Genentech Overview EMMA Data Issues What did we do? 2 2 Roche Group An innovation network 3 South San Francisco is home

More information

Compassionate Use Navigator Information for Physicians

Compassionate Use Navigator Information for Physicians Compassionate Use Navigator Information for Physicians Contact: Elena Gerasimov, Program Director, Elena@kidsvcancer.org. As a physician, you must have wished there would be more treatment options for

More information

Unique Device Identifiers (UDIs) The Next Big Step for Effective Analysis. Bill A. Bobbie President, Cook (Canada) Inc.

Unique Device Identifiers (UDIs) The Next Big Step for Effective Analysis. Bill A. Bobbie President, Cook (Canada) Inc. Unique Device Identifiers (UDIs) The Next Big Step for Effective Analysis Bill A. Bobbie President, Cook (Canada) Inc. May 16, 2017 Agenda UDI Background A Manufacturer s Journey Implemen;ng UDI Labels

More information

Hub Performance Assessment

Hub Performance Assessment Hub Performance Assessment Hub complex performance assessment will be assessed with a standardized report card mechanism. The report card draws on data quality reports, enrollment reports, and monitoring

More information

Clinical Trials Series Part II

Clinical Trials Series Part II Clinical Trials Series Part II Agenda Recap December Presentation J. Schmelz Example: New CT from HSC Investigator Non Cancer Clinical Trial J. Bates, P. Miranda Example: New CT from External Entity Non

More information

ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016

ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016 UCLA CTSI WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016 Objectives Define the sponsor of a clinical trial and learn

More information

Compliance and Quality Monitoring: What, Why, When, and How

Compliance and Quality Monitoring: What, Why, When, and How Compliance and Quality Monitoring: What, Why, When, and How Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Research Institute, University

More information

Research 101. Health Care Compliance Association Regional Conference Columbus, Ohio May 8, 2015

Research 101. Health Care Compliance Association Regional Conference Columbus, Ohio May 8, 2015 Research 101 Health Care Compliance Association Regional Conference Columbus, Ohio May 8, 2015 Jennifer Lanter, MSPH, BSN, RN, CCRC Director, Research & Special Billing Office Agenda Research Compliance

More information

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Copyright 2009 - Pharmaceutical Research & Manufacturers Association 1 Overview Audit ICH-GCP,

More information

SOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018

SOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018 SOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018 CLINICAL TRIALS FINANCIAL MANAGEMENT ADMINISTRATIVE CHALLENGES & CONSIDERATIONS Agenda 1. Introduction 2. Challenges in Clinical Trial Financial

More information

Workforce Management KPIs That Ma)er

Workforce Management KPIs That Ma)er Businesses Run Be)er on Kronos Workforce Ready Workforce Management KPIs That Ma)er Sponsored by 1 Kronos Workforce Ready Delivers Key Performance Indicator (KPI) Improvements to Customers Helping organisahons

More information

Laboratory Information system is. Laboratory Information System

Laboratory Information system is. Laboratory Information System Laboratory Information System The Laboratory Information system module is used by the pathology lab to record and disseminate the information regarding the tests performed. The Laboratory department receives

More information

Project Management. Project Planning CE PROJECT MANAGEMENT L- 5

Project Management. Project Planning CE PROJECT MANAGEMENT L- 5 Project Management Project Planning CE 447 - PROJECT MANAGEMENT 1 L- 5 Project Phases 1. Ini7a7on 2. Planning 3. Execu7on 4. Controlling 5. Closing Planning Phase Communica7on plan Scope management plan

More information

IT System Scope Development. Presented by Lourdes Coss, MPA, CPPO

IT System Scope Development. Presented by Lourdes Coss, MPA, CPPO IT System Scope Development Presented by Lourdes Coss, MPA, CPPO Objec4ves Discuss Key Components of an IT System Scope of Services Prac?ce the Development of the Document Discuss some of the laws of teamwork

More information

American Samoa Community College

American Samoa Community College American Samoa Community College Fall 2015 Convoca8on Accredita8on Status August 10, 2015 Our purpose is our Mission The mission of the American Samoa Community College is to foster successful student

More information

AASBO May /1/17. Posi*on Control as a Management Tool. Posi2on Control Basics Master Posi2on

AASBO May /1/17. Posi*on Control as a Management Tool. Posi2on Control Basics Master Posi2on AASBO May 2017 Posi*on Control as a Management Tool Objec2ves of Posi2on Control Ensure that all Employees are Assigned to Authorized and Funded Posi*ons Streamline Workflow Between HR and PR Eliminate

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS CLINICAL TRIALS FREQUENTLY ASKED QUESTIONS PARTICIPATING IN A CLINICAL TRIAL What is a clinical trial? Clinical trials are research studies that involve people. Through clinical trials, researchers find

More information

Using NIHR validated workforce tools to determine capability & capacity at UHB

Using NIHR validated workforce tools to determine capability & capacity at UHB Using NIHR validated workforce tools to determine capability & capacity at UHB Joanna Gray Fiona McGlynn Sarah Dhariwal Joanne Plumb Aims To identify and share workforce planning solutions at University

More information

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS Catherine Jahrsdorfer, R.N., B.S.N. Director of Clinical Services Office of Clinical Research January 2 & 3, 2012 Learning

More information

St. Luke s University Health Network

St. Luke s University Health Network Page 1 of 5 PURPOSE: This standard operating procedure (SOP) applies to the activities involved in the collection and handling of laboratory specimens from patients enrolled in clinical studies subject

More information

Diabetes Obesity Control Program

Diabetes Obesity Control Program Diabetes Obesity Control Program Pre-Read for External Review Prepared by Lynda Chin June 2016 For the Blue Ribbon Panel Use Only Confiden8al Do Not Distribute 1 Chronic Disease Burden Worldwide: $47 trillion

More information

Beyond Hydraulic Fracturing Chemicals: Beneficial Reuse of Oil Field Produced Water for Irriga>on of Agriculture

Beyond Hydraulic Fracturing Chemicals: Beneficial Reuse of Oil Field Produced Water for Irriga>on of Agriculture Beyond Hydraulic Fracturing Chemicals: Beneficial Reuse of Oil Field Produced Water for Irriga>on of Agriculture Seth B.C. Shonkoff, PhD, MPH 1,2,3 1 PSE Healthy Energy, Inc. 2 University of California,

More information

Study Files and Filing

Study Files and Filing Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm

More information

MVP Access Program Access to Data and Sera collected during the MenAfriVac clinical trials

MVP Access Program Access to Data and Sera collected during the MenAfriVac clinical trials MVP Access Program Access to Data and Sera collected during the MenAfriVac clinical trials 23 February 2016 The MVP Closure Conference Lionel Martellet Clinical Opera0ons Manager Presenta;on Overview 1.

More information

EHR 2.0 Collaboration

EHR 2.0 Collaboration 2.0 Collaboration Electronic Health Records User Experience October 5, 2010 Tina Buop CIO, Muir Medical Group IPA,., Inc Debra Spindel VP, Nautilus Healthcare Management Group, LLC Agenda Introduction

More information

Case Study: University of Washington s Clinical Research Billing Audit Program

Case Study: University of Washington s Clinical Research Billing Audit Program Case Study: University of Washington s Clinical Research Billing Audit Program 7 th Annual Conference for Effective Compliance Systems in Higher Education Richard A. Meeks, CCEP Agenda Background Probe

More information

SWOG

SWOG SWOG http://swog.org Page 1 of 5 pages Original Release Date: July 1985 Departments Affected: All Revision Date: April 2018 Introduction SERIOUS ADVERSE EVENTS The timely reporting of serious adverse events

More information

AR-CRIS Comprehensive Research Informatics Suite ANGIE SMITH, MS, CCRP, PMP DIRECTOR OF IT RESEARCH SYSTEMS UAMS IT RESEARCH

AR-CRIS Comprehensive Research Informatics Suite ANGIE SMITH, MS, CCRP, PMP DIRECTOR OF IT RESEARCH SYSTEMS UAMS IT RESEARCH AR-CRIS Comprehensive Research Informatics Suite ANGIE SMITH, MS, CCRP, PMP DIRECTOR OF IT RESEARCH SYSTEMS UAMS IT RESEARCH Overview of AR-CRIS Arkansas Comprehensive Research Informatics Suite (AR-CRIS)

More information

Kentucky PCA Annual Mee0ng October, Coleman Associates. The Hub of the PCMH Coleman Associates. Let me in!

Kentucky PCA Annual Mee0ng October, Coleman Associates. The Hub of the PCMH Coleman Associates. Let me in! Improving Patient Access By Revamping Your Schedule and Managing Your Pa0ent Popula0on 1 The Hub of the PCMH 2 Let me in Give me the best What Pa6ents Want Don t waste my 6me Figure me out & fix me Care

More information

MAP KEYS OVERVIEW and CASE STUDY Thursday, March 10, to 3:30 pm

MAP KEYS OVERVIEW and CASE STUDY Thursday, March 10, to 3:30 pm Association of Illinois Access Management Patient Access No Bed of Roses Rosewood Restaurant, Rosemont, IL MAP KEYS OVERVIEW and CASE STUDY Thursday, March 10, 2011-2 to 3:30 pm Suzanne K. Lestina, FHFMA,

More information

Presenters Details: Saul Jankelow Title of Presenta5on: So6ware as a medical device Date: 24 August 2017

Presenters Details: Saul Jankelow Title of Presenta5on: So6ware as a medical device Date: 24 August 2017 Presenters Details: Saul Jankelow Title of Presenta5on: So6ware as a medical device Date: 24 August 2017 So#ware as a medical device (SaMD) So6ware has become cri5cally important in the efficient running

More information

External IRB Review What Does it Mean for Your Institution

External IRB Review What Does it Mean for Your Institution External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA

More information

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout. Wednesday October 10, 2012 Please be sure to sign in and take copies of each handout. 1 Alicia Joy, IRB 2 FH Office of Research Administration Christina Jackson, BSN, RN, CCRC, CHRC 1 ClinicalTrials.gov

More information

Using Technology to Reduce Costs and Improve Quality

Using Technology to Reduce Costs and Improve Quality Using Technology to Reduce Costs and Improve Quality Kari Cornicelli, FHFMA, CPA VP, CFO Sharp Grossmont Hospital SOHL, HIMSS, and HFMA Joint Chapter Meeting 9/20/12 HFMA s Value Project Objectives Understand

More information

SERIOUS ADVERSE EVENTS

SERIOUS ADVERSE EVENTS EVENTS Introduction Timely reporting of Serious Adverse Events (SAEs) is required by regulations of the Food and Drug Administration (FDA) and the National Cancer Institute (NCI). Such reporting is not

More information

Details: Approval: Distribution & Storage:

Details: Approval: Distribution & Storage: Details: Author: Neville Young Quality Assurance Manager SOP Pages: Version No. of replaced SOP: Effective date of replaced SOP: NA NA Approval: Version No: of the SOP being approved. Name of person approving

More information

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014 Clinical Trials and the Code of Federal Regulations Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014 The Development of Regulations 1906: Food and Drugs Act

More information

Disrup'ng the Status Quo of Reac've Pricing

Disrup'ng the Status Quo of Reac've Pricing Disrup'ng the Status Quo of Reac've Pricing Jeremy Pifer Director of Pricing Hologic: The Science of Sure Innova've healthcare company with market- leading products for early detec'on and interven'on,

More information

Empowering Students Through Peer Mentorship. NAFSA Northern District Conference March 13, 2017

Empowering Students Through Peer Mentorship. NAFSA Northern District Conference March 13, 2017 Empowering Students Through Peer Mentorship NAFSA Northern District Conference March 13, 2017 Keri Toma Interna;onal Programs Coordinator UC Santa Cruz Today s Plan 1. UC Santa Cruz Interna;onal Mentorship

More information

Clinical Trials Billing Audit Internal Audit Report 18:02

Clinical Trials Billing Audit Internal Audit Report 18:02 Office of Internal Audit Clinical Trials Billing Audit Internal Audit Report 18:02 October 12, 2018 Table of Contents I. Executive Summary 3 Background 3 Scope and Objectives 5 Conclusion 6 II. Detailed

More information

EPIC UPGRADE NOVEMBER 2017 RESEARCHER NOTES FOR STUDY-RELATED IMAGING

EPIC UPGRADE NOVEMBER 2017 RESEARCHER NOTES FOR STUDY-RELATED IMAGING EPIC UPGRADE NOVEMBER 2017 RESEARCHER NOTES FOR STUDY-RELATED IMAGING Use of the current paper Radiology Research Order forms will be discontinued in conjunction with EPIC go-live. After EPIC go-live,

More information

The RIGHT care, at the RIGHT time, for the RIGHT outcome.

The RIGHT care, at the RIGHT time, for the RIGHT outcome. The RIGHT care, at the RIGHT time, for the RIGHT outcome. The New WSIB Surviving the Changes? Unlocking the Secret to WSIB Management Liz R. Scott, PhD Principal Organizational Solutions Inc. AGENDA Introduc/on

More information

ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL

ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL Assemble Essential Documents in Trial Master File (TMF) Appendix 1 ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL 8.2 Before the Clinical Phase of the Trial Commences During this planning stage

More information

EuroNet- PHL- C2 trial set- up and trial monitoring

EuroNet- PHL- C2 trial set- up and trial monitoring EuroNet- PHL- C2 trial set- up and trial monitoring Chris9ne Mauz- Körholz Department of Pediatrics Pediatric Hematology and Oncology UKGM, Justus- Liebig University of Gießen, Germany ScienCfic Secretary

More information

Resurrection Health Care Transforming Document Processing with Intelligent Data Capture

Resurrection Health Care Transforming Document Processing with Intelligent Data Capture Resurrection Health Care Transforming Document Processing with Intelligent Data Capture Today s Guest Speaker Robert Banwart Director of Accounts Payable Resurrec'on Health Care Company Experience: Sun

More information

Your Hospital. Food & Nutrition Service Excellence Boot Camp. Featuring Chris Thrash. Prepared for: Prepared by:

Your Hospital. Food & Nutrition Service Excellence Boot Camp. Featuring Chris Thrash. Prepared for: Prepared by: Food & Nutrition Service Excellence Boot Camp Featuring Chris Thrash Prepared for: Prepared by: Innovative ity Solutions, Inc. 35473 Red Tail Road Lewes, DE 19958 302-231-2333 Project Overview Crea)ng

More information

GLOBAL Trend and opportunities in drug development

GLOBAL Trend and opportunities in drug development GLOBAL Trend and opportunities in drug development พญ อรณ ต งเผ า Oranee T Daniels MD October 2015 Looking back during last 15 years Drug safety became a focus for both regulators and drug developers.

More information

President. Duties & Responsibilities. Skill Requirements Leadership, coaching, mentoring, and motivation

President. Duties & Responsibilities. Skill Requirements Leadership, coaching, mentoring, and motivation IABC Chapter Leader Job Description Template IABC has developed these suggested board roles for chapters to adopt. Chapters may use these descriptions as a template and can customize each role to meet

More information

4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site.

4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site. POLICY #: RCO-203 Page: 1 of 7 1. POLICY STATEMENT: Essential regulatory documents will be on maintained for research sponsored by or conducted at Dana-Farber/Harvard Cancer Center (DF/HCC) to assure compliance

More information

MMC-Einstein Research IT Forum

MMC-Einstein Research IT Forum MMC-Einstein Research IT Forum June 7, 2017 Harry Shamoon, Associate Dean for Clinical & Translational Research Barrett Katz, Executive Director, Office of Clinical Trials Vic Hatcher, Associate Dean for

More information

Richard Close Pfizer, Inc. Groton, CT Professional Experience

Richard Close Pfizer, Inc. Groton, CT Professional Experience Richard Close Pfizer, Inc. Groton, CT 860-501-3117 Richard.close@pfizer.com Richard Close Professional Experience Executive Director, Pfizer, Inc. Development Operations, Clinical Informatics and Innovation

More information

DRUG ORDERING AND MAINTENANCE

DRUG ORDERING AND MAINTENANCE AND MAINTENANCE Disclaimer: Please note that the instructions provided in this chapter mainly apply to agents provided by the Pharmaceutical Management Branch (PMB), of Cancer Therapy Evaluation Program

More information

Research Governance Policy and Procedure

Research Governance Policy and Procedure Research Governance Policy and Procedure Version: 5 Name of originator/author: Name of executive lead: Date ratified: Review date: APPLICABLE TO: All staff. EXECUTIVE SUMMARY Dr Lisa Austin- University

More information

Sponsor-Investigator Responsibilities In Clinical Trials

Sponsor-Investigator Responsibilities In Clinical Trials In Clinical Trials Margaret Huber, RN, BSN, CHRC Compliance Manager The lecturer has no conflicts for this presentation 9/23/2015 Objectives Define terms sponsor, investigator, and sponsor-investigator.

More information

Long Term 2 Enhanced Surface Water Treatment Rule & Ground Water Rule Updates for Oklahoma Water Systems

Long Term 2 Enhanced Surface Water Treatment Rule & Ground Water Rule Updates for Oklahoma Water Systems Long Term 2 Enhanced Surface Water Treatment Rule & Ground Water Rule Updates for Oklahoma Water Systems June 2014 October 1, 2013 Administra5on of three Drinking Water Rules transferred from EPA to Oklahoma

More information

Final Outcome of ASW Symposium

Final Outcome of ASW Symposium Symposium on the ASEAN Single Window and National Single Windows Borobudur Hotel, Jakarta, Indonesia 18 September 2012 Summary of Session 5 Final Outcome of ASW Symposium 1 ü The current ASW architecture

More information

UCLA UCPath Update. Common Systems Group. July 28, UCPath at UCLA. Confiden'al. For internal UCLA use only.

UCLA UCPath Update. Common Systems Group. July 28, UCPath at UCLA. Confiden'al. For internal UCLA use only. UCLA UCPath Update Common Systems Group July 28, 2015 Confiden'al. For internal UCLA use only. Agenda Scope of UCPath Project governance How we got here Scope of work for UCLA Campus systems effort: Data

More information

New gtld Program Update! 08 April 2013! Chris&ne Wille, ICANN, VP gtld Opera&ons

New gtld Program Update! 08 April 2013! Chris&ne Wille, ICANN, VP gtld Opera&ons New gtld Program Update! 08 April 2013! Chris&ne Wille, ICANN, VP gtld Opera&ons Agenda! + Accomplishments since Toronto meeting + Timeline + Application Processing - Initial Evaluation Status - Objections

More information

SYSTOC Designed specifically for occupational medicine clinics and practices

SYSTOC Designed specifically for occupational medicine clinics and practices SYSTOC Designed specifically for occupational medicine clinics and practices Real-Time Healthcare Requires Real-Time Records Your customers require the highest quality occupational healthcare for their

More information

Clinical Trial Transparency UK perspective

Clinical Trial Transparency UK perspective Clinical Trial Transparency UK perspective Dr Bina Rawal Medical, Innovation & Research Director Association of the British Pharmaceutical Industry January 2014 1 Outline Transparency timeline Campaign

More information

Expanded Access and the Individual Patient IND

Expanded Access and the Individual Patient IND Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office

More information

Sponsorship of Clinical Research Studies

Sponsorship of Clinical Research Studies Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use

More information

Melanie Hawkins, BSN, RN, CCRC Director, Clinical Research Billing Compliance Kristin Pattee Couture, CCRP Clinical Research Coverage Analyst

Melanie Hawkins, BSN, RN, CCRC Director, Clinical Research Billing Compliance Kristin Pattee Couture, CCRP Clinical Research Coverage Analyst NEW CLINICAL RESEARCH BILLING SCHEDULE Melanie Hawkins, BSN, RN, CCRC Director, Clinical Research Billing Compliance Kristin Pattee Couture, CCRP Clinical Research Coverage Analyst What is a billing schedule

More information

Demystifying Audits. Audits and Audit Preparation 5/23/2016. What is an Audit?

Demystifying Audits. Audits and Audit Preparation 5/23/2016. What is an Audit? Demystifying Audits Darlene Kitterman, MBA Director, Investigator Support & Integration Services OCTRI May 26, 2016 Audits and Audit Preparation What is an Audit? A systematic and independent examination

More information

June 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB

June 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB June 15, 2016 Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB About Schulman IRB Established in 1983 Superior audit history with FDA five consecutive audits

More information

NEUROENDOVASCULAR TRIALS

NEUROENDOVASCULAR TRIALS 1 NEUROENDOVASCULAR TRIALS Understanding your Research Role in Stroke and Device Trials Tuesday, June 09, 2015 2 Biography Christy Anton is a Clinical Research Coordinator at Rush University Medical Center.

More information

Building Cultural Competence through Sustainable Change: Findings from the NCHL Diversity Leadership Demonstra?on Project

Building Cultural Competence through Sustainable Change: Findings from the NCHL Diversity Leadership Demonstra?on Project Building Cultural Competence through Sustainable Change: Findings from the NCHL Diversity Leadership Demonstra?on Project Judith G. Bryant, MSOD NCHL Diversity Leadership Organizational Coach Judithbryant@consultant.com

More information

A Panoramic View of Campus Shared Services

A Panoramic View of Campus Shared Services A Panoramic View of Campus Shared Services Peggy Huston, Chief Opera,ng Officer, Campus Shared Services Cathy Jen, Service Director, Campus Shared Services Team 2/ERSO Sandi Ketchpel, Assistant Dean of

More information

The Research Services Organization (RSO) of the Academic Health Center

The Research Services Organization (RSO) of the Academic Health Center Annual Report 2005 The Research Services Organization (RSO) of the Academic Health Center A Summary of the Eighth Year of Operations Submitted by: Mark S. Paller, M.D., M.S. Director, Research Services

More information

Optimizing your Billing Process

Optimizing your Billing Process Optimizing your Billing Process Samantha Charles Greenfield Health GreenField Health Fee based practice founded in 2001 Seven physicians in two locations Four integrated business units Redesigned medical

More information

Optimizing Triple Aim Performance via Incentives, Transparency, and Best Practice Implementation

Optimizing Triple Aim Performance via Incentives, Transparency, and Best Practice Implementation Optimizing Triple Aim Performance via Incentives, Transparency, and Best Practice Implementation Mary Barton Durfee, MD Executive Vice President & Chief Medical Officer Richard Duffy, MBA Vice President

More information

DRUG ORDERING AND MAINTENANCE

DRUG ORDERING AND MAINTENANCE AND MAINTENANCE Disclaimer: Please note that the instructions provided in this chapter only apply to agents provided by the Pharmaceutical Management Branch (PMB), of Cancer Therapy Evaluation Program

More information

Work Instruction - Research Billing Risk

Work Instruction - Research Billing Risk THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO Work Instruction - Research Billing Risk Velos eresearch Version 9.2 Version: 2.0, 04/03/2015 Revision History Version/Amendment #: Version

More information

I. Purpose. II. Definitions. Last Approval Date

I. Purpose. II. Definitions. Last Approval Date Investigational Drugs and Biologics Page 1 of 13 I. Purpose The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics

More information

DEVELOPING CLINICAL TRIALS INFRASTRUCTURE

DEVELOPING CLINICAL TRIALS INFRASTRUCTURE DEVELOPING CLINICAL TRIALS INFRASTRUCTURE SESSION IV of IOM Workshop: Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020 PAUL EISENBERG PETRA KAUFMANN

More information

Index of Standard Operating Procedures for all research Sponsored by the UHL

Index of Standard Operating Procedures for all research Sponsored by the UHL University Hospitals of Leicester NHS Trust () Index of Standard Operating Procedures for all research Sponsored by the March Please note that with effect from 2015, all SOPs and Appendices use the same

More information

UT SOUTHWESTERN MEDICAL CENTER AT DALLAS INSTITUTIONAL REVIEW BOARD. Emergency Use of an Investigational Drug, Biologic or Device

UT SOUTHWESTERN MEDICAL CENTER AT DALLAS INSTITUTIONAL REVIEW BOARD. Emergency Use of an Investigational Drug, Biologic or Device Emergency Use of an Investigational Drug, Biologic or Device Introduction The emergency use provision in the FDA regulations (21 CFR 56.102d) is an exemption from prior review and approval by the IRB for

More information

Clinical Research Billing Systems

Clinical Research Billing Systems Clinical Research Billing Systems Internal Audit Report No. I2017-202 January 30, 2017 Prepared By Mike Shead, Senior Auditor Reviewed By Niran Joshi, Associate Director Approved By Mike Bathke, Director

More information